HOYA Announces MyoSmart Lenses

0
4109

HOYA Corporation announces a new product launch in Summer 2018: MyoSmart with D.I.M.S. Technology to reduce myopia progression in myopic children and teenagers.

Clinical research shows children wearing the lenses have significantly less myopia.

HOYA Corporation, a key player in the global market for ophthalmic lenses, is proud to announce a new product launch in Summer 2018: MyoSmart with D.I.M.S. Technology, a lens for myopia control in children and youth, developed in cooperation with our partner, The Hong Kong Polytechnic University. Wearing defocus spectacles daily significantly slows myopia progression and axial elongation in myopic school children aged 8 to 13, according to a two-year double-blind randomized clinical trial in which 160 Chinese myopic children in Hong Kong participated. Following the trial, which began in 2014, children wearing defocus lenses had 60 percent less myopia progression and in 21.5 percent of the children, the myopia progression halted completely. The findings provide strong evidence that defocus lenses are effective in reducing myopia progression.

In 2012, HOYA Corporation and The Hong Kong Polytechnic University launched a cooperation with the focus on developing a new myopia control lens which is capable of preventing myopia from worsening or slowing down its progression.

Following years of academic studies, product design and clinical research, HOYA Corporation and The Hong Kong Polytechnic University developed a revolutionary spectacle lens, based on a Defocus Incorporated Multiple Segments Technology or “D.I.M.S. Technology”, which just successfully won the Grand Prize, Grand Award and Gold Medal at the 46th International Exhibition of Inventions of Geneva in April 2018.

The lens, which has a smooth surface and looks almost identical to a regular lens was presented on the 6 March at a symposium in Shanghai which was organized by Hoya. A second successful symposium for key opinion leaders, “Symposium of Defocus Theory and Clinical Results in Myopia Control”, was held at Hong Kong Hyatt Regency Hotel on 25 April, organized by Hoya Lens HK Ltd. and the Global Marketing team.

Additionally, Hoya Faculty organized an International symposium on myopia, which took place in Budapest in May 2018. There, 11 International and European experts exchanged views and insights on myopia control in general, as well as on our new MyoSmart lens.
These events were attended by more than 40 key opinion leaders and the D.I.M.S. technology was very well received.

MyoSmart lenses will be launched in Hong Kong and China in the summer of 2018. A broader, global launch is slated to begin in 2019/2020.

About HOYA

Founded in 1941 in Tokyo, Japan, Hoya is a global technology and med-tech company, and a leading supplier of innovative high-tech and medical products. Hoya is active in the fields of healthcare and information technology, providing eyeglasses, medical endoscopes, intraocular lenses, optical lenses, as well as key components for semiconductor devices, LCD panels and HDDs. With over 150 offices and subsidiaries worldwide, Hoya currently employs a multinational workforce of over 37,000 people. For more information, please visit http://www.hoya.com.

About HOYA Vision Care

For over 60 years, HOYA Vision Care has been a global leader in the eyeglass lens business. With a presence in over 50 countries, Hoya Vision Care has a proven expertise in lens designs and freeform surfacing technology combined with a leading position in high performance, quality AR coating. HOYA Vision Care’s solid market portfolio includes SEIKO and PENTAX optical lenses, as well as innovative products such as Hoyalux iD MyStyle V+ progressive lenses and Yuniku, vision-centric 3D tailored eyewear. The company employs over 16,000 employees worldwide with mass production facilities in Asia & Europe and over 40 local Rx laboratories globally.

Feb31 Mid 519